CorMedix, Inc. (CRMD)
8.82
+0.17
(+1.97%)
USD |
NASDAQ |
Jun 10, 13:55
CorMedix EPS Diluted (Quarterly) : 0.4151 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.2139 |
| Eloxx Pharmaceuticals, Inc. | -0.8566 |
| Cannabis Global, Inc. | 0.00 |
| BioStem Technologies, Inc. | -0.5234 |
| Axsome Therapeutics, Inc. | -1.261 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 38.60M |
| Revenue (Quarterly) | 127.43M |
| Total Expenses (Quarterly) | 88.83M |
| Enterprise Value | 644.26M |
| Gross Profit Margin (Quarterly) | 82.50% |
| Profit Margin (Quarterly) | 30.29% |
| Earnings Yield | 23.80% |
| Operating Earnings Yield | 25.46% |
| Normalized Earnings Yield | 24.55 |